Several laboratories, including ours, have reported (10-18) that processing times and resolution in steroid receptor assays can be improved if size-exclusion "high-performance" liquid chromatography (SEHPLC) is used. Since the appearance of our first report (10) on this topic, we have identified several factors affecting the reproducibility of the recovery rate in steroid receptor elutions. Here, we discuss these considerations, and also the relative useful life of SEHPLC columns, to enhance the utility of this method in clinical laboratories. 
and molecular events that program those physiological responses that culminate in tissue growth (1-3). Observation of hormone-induced growth in certain tumors has led to identification of many of the same molecular components in normal and tumor tissue (4) (5) (6) . In particular, the demonstration of a system in which steroid is bound by a cytoplasmic protein (i.e., "estrogen receptor"), which interacts with clromatin, establishes some basic criteria for the identification of hormone responsiveness (7, 8) . The response of breast-cancer patients to endocrine therapy increases as a function of estrogen receptor concentration in the tumor (9). The response is greatest when the tumors are positive for both estrogen and progesterone receptors (8).
Several laboratories, including ours, have reported (10-18) that processing times and resolution in steroid receptor assays can be improved if size-exclusion "high-performance" liquid chromatography (SEHPLC) is used. Since the appearance of our first report (10) on this topic, we have identified several factors affecting the reproducibility of the recovery rate in steroid receptor elutions. Here, we discuss these considerations, and also the relative useful life of SEHPLC columns, to enhance the utility of this method in clinical laboratories.
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Buffers
We varied the concentration of K2HPO4 between 200 mmol/L (buffer Pms) and 10 mmolJL (buffer P10), but kept the pH at 7.4. All elution buffers contained 75 mL of dimethylformamide per liter.
Procedures
Preparation of cytosols. Freshly removed mouse uteri, freed of fat and mesenteric tissue, were homogenized in P buffer (five uteri per milliliter of buffer). After centrifugation at 2000 x g for 15 ruin to remove the nuclearmyofibrillar material, we recentrifuged the supernate at 105 000 x g for 30 rain. The supernate obtained at the higher speed was mixed with sodium molybdate (iO mmol/L, final concentration) unless otherwise specified.
Receptor determinations.
Estrogen receptor preparations
were supplemented with 10 ninol of [3H]estradiol per liter to determine total binding activity. For determinations of nonspecific binding, parallel incubations contained unlabeled diethylstilbestrol (2 imol/L) as competitor (19). Specific receptor binding was determined as the difference between total and nonspecific binding (19) (20) (21) . Androgen receptors were determined for preparations homogenized in TEMG buffer (20) , after adding 10 nmol of [3H]R1881 per liter, with use of 2 mol of unlabeled dihydrotestosterone per liter (20) , as competitor. We used dextran-coated charcoal (5g of charcoal and 0.5 g ofDextran C in 100 mL of 10 mmoIJL Tris buffer) to remove unbound ligand (21,22), one volume of the charcoal slurry to nine volumes of cytosol. The radioactivity not absorbed was regarded as "bound" radioactivity. For liquid scintillation counting we used "Scinti Verse E" fluor (Fisher Scientific Co., Fairlawn, NJ 07410), and automatically corrected each sample for quench (23) . Concentrations of soluble protein were determined accordingto the method of Lowry et al. (24) .
Size-exclusion chromatography.
All buffers were membrane-filtered with Millipore HATF ultrafiltration membranes to remove particulates.
Supernates from high-speed centrifugation were ifitered through membrane ifiters with low protein-binding properties (Millex GV), to remove components that impair column performance.
For isocratic elution we used a flow-metered pump (Model 112; Beckman Instruments, Berkeley, CA 94710) to deliver buffer to Spherogel-TSK-SW exclusion columns (G-2000, G-3000, or G-4000, 21.5 x 600 mm; Beckman Instruments) fitted with guard columns (Spherogel-TSK precoluinns SW, 21.5 x 100 mm). "Tandem" columns consisted of a TSK-G2000SW guard column and a TSK-G3000SW column (21.58 x 300 mm) linked to a TSK-G4000SW column (21.5 X 300 mm). We injected samples with a syringe-loaded injector (Model 210; Beckman Instruments) fitted with a 250-FL sample loop (10, 11), then eluted the steroid receptors with Poo buffer containing 75 mL of dimethylformamide per liter, except where otherwise indicated. We measured absorbance at 280 nm with a fixed-wavelength detector (ChemResearch Model 2020; Isco Co., Lincoln, NE 68504), and collected 1-mL fractions of column effluent with a rapid-response programmable fraction collector (Foxy; Isco Co.). The chromatographic system was maintained and operated at 2 to 5#{176}C. For routine maintenance, after every eight to 10 injections we washed the column with P10 buffer containing NaCl (300 mmol/L, pH 6.0), at 1 mL/min, until all 280-nm absorbing material was eluted from the column; usually this took about 2-4 h. When this routine was inadequate for restoring low column back-pressures at 1 mL/min elution rates, we washed the column with distilled water at the same rate until all salts were removed. This required longer than 2 h. Any proteins still adhering to the column were then purged with a 100 mJJL solution of dimethyl sulfoxide in methanol for 12 to 24 h at 0.1 mLlmin. After passing 100% methanol through the column for about 8 h at 0.1 mL/min, we pumped methylene chloride through to remove lipids (12-24 h, 0.1 mL'min). To prepare the column for accepting aqueous buffers, we pumped methanol through it at 0.1 mLlmin for about 6 h, then at 1 mLlmin for 4-8 h, followed by distilled water, 0.1 mL/min for first hour, then 1 mLfmin for 1-4 h.
Treatment of receptor preparations:
Supernates from the high-speed centrifugation were membrane filtered, dissolved in P200 buffer containing 100 mL of glycerol per liter, and stored at -70 #{176}C in 2-mL aliquots. Storage temperature was maintained at a (recorded) constant temperature of -70 #{176}C. To thaw samples, we placed them for 5 mm in an ice slurry, then manually swirled them in a water bath set at 30#{176}C until they were just liquid. This took about 2 to 4 mm.
Cytoplasmic receptors dissolved in P#{174} buffer were prepared for lyophilization by decanting 0.5-mL aliquots of this preparation into 5-mL glass vials then shell frozen-i.e., manu 3lly swirled in an acetone/solid CO2 slush to provide the maximum surface area for lyophilization.
To ensure 
Results
Sample Preparationand ElutionConditions
Because column life can be extended by membrane filtration of aqueous biological preparations, we explored the use of membrane ifiters to prepare high-speed supernates for SEHPLC analysis. Retention of estrogen receptor was lowest on Millex GV ifiters and was inversely related to the concentration of soluble protein in the preparation ( Figure  1 ).
Receptor recovery can be dramatically improved by including dimethylformamide in the elution buffer, which does not affect receptor elution or the elution of marker proteins (25) .
The ionic strength of the elution buffer is significant for separating different receptor forms on the TSK-SW column series (10, 17,26-30) .
If the ionic strength is too low, even small receptor forms tend to be excluded on these columns and hydrodynamic receptor size will be overestimated. Figure 2 shows that large hypotomcally prepared cytoplasmic receptors are excluded regardless of the ionic strength of the elution buffer (A-H), whereas smaller trypsinized cytoplasmic receptors are partly excluded in elution buffer of low ionic strength but can be chromatographed at higher ionic strength (I-P). As Figure 2 also illustrates, large native cytoplasmic receptors are excluded on TSK-G2000SW columns so that when both large and small receptor forms are contained in a preparation, they can be separately resolved.
The pH of the elution buffer must be maintained at or below neutral to prevent the decomposition of the TSK-SW columns. Below pH 5, receptors are not eluted and column back pressure increases quickly unless steps are taken. Ordinarily, consecutive samples can be injected onto the columns if 20 mL of P buffer is eluted after each run to ensure a return to a low baseline. Thus, the sequential analyses of radiolabeled ligand alone followed by labeled ligand plus unlabeled competitor can be made at neutral pH so that baseline counts are low in the first few fractions of each elution ( Figure 3A, B) ; at pH 6.5 and 5.5 the baseline counts increase (Figure 3C, D) . Perhaps components in the receptor preparations interact with the TSK-SW columns as the pH is lowered so that receptors fail to be eluted at low pH (s pH 5).
Performance of the TSK-SW Series SEHPLC Columns
Elution of various reference proteins on columns of the TSK-SW series has been well documented (10, 25-0); their capacity for fractionation is shown in Figure 4 . Although large hypotonically prepared cytoplasmic receptors would be expected to be best resolved on the TSK-G4000SW and TSK-G3000SW columns, utility in the clinical laboratory must take into account column life. While the K-G2000SW column has the greatest useful life, large cytoplasmic receptor forms are excluded and can not be chromatographed on this column. However, small receptor forms are completely resolved on this column (see below) so that large excluded cytoplasmic receptors can be distinguished from smaller receptor forms. The TSK-G2000SW may thus be the most useful for SEHPLC assay of steroid receptors in clinical laboratories.
Regardless of the column chosen, finite column life indicates that frequent calibration is prudent. Shifts in peak absorbance around 280 nm provide a general monitor and method for alignment of elution proffles. Columns under heavy use may require recalibration with protein standards every four to six weeks.
Elution Profiles of Steroid Receptor Preparations
As reported previously (10), murine cytoplasmic estrogen receptors behave chromatographically on TSK-G3000SW Figure 5F ) than receptors in the crude preparation ( Figure SE) , and cytoplasmic estrogen receptors that had been deaggregated by treatment with KC1 (400 mmol/L) eluted later (Ve = 17 mL; Figure 5G ) than large, hypotonically prepared cytoplasmic receptors ( Figure 5E ). By using conditions recognized as sufficient for activation (3,32), we converted these later-eluting receptor forms to larger, earlyeluting forms (Figure 511) . Thus, receptor activation, which 1, 2, 31, 32) , can also be assessed by elution from TSK-G2000SW columns. This change has not been resolved on TSK-G3000SW columns (data not shown). As Figure 6 shows, cytoplasmic receptors that had been deaggregated with 3 mol/L urea eluted later on TSK-G2000SW columns (Ve =18 niL) than hypotonically prepared cytoplasmic receptors (Ve = 14 mL) or cytoplasmic receptors exposed to 500 mmoVL NaSCN (Ve 16 mL), but not as late as did trypsinized cytoplasmic receptors (Ve = 20 mL). Exposure of nuclei to 400 mmol/L KC1 for 60 miii at 0-4#{176}C extracts nuclear estrogen receptors (1, 2, 10, 23) . Because extracted nuclear receptor activity is often lower than receptor activity in cytoplasmic receptor preparations, dissociation of radioligand during SEHPLC at ambient temperatures can considerably decrease the specifically bound radioligand (Figure 7B) , especially as compared with elution at 2#{176}C (Figure 7A) , where dissociation is slower. Elution of nuclear receptors on tandem columns ( Figure 7C) was not distinct from the elution of cytoplasmic (Figure SB) or KC1-deaggregated cytoplasmic receptors ( Figure SD) . The KC1-extracted nuclear receptors ( Figure 7D ; Ve = 14 mL) were eluted on TSK-G2000SW columns with profiles identical to those of activated cytoplasmic receptors ( Figure  5K ; Ve =14 mL). Nuclear estrogen receptors released from chromatin by either brief (4 miii) or more prolonged (60 miii) exposure to deoxyribonuclease I (EC 3.1.21.1) tended to be eluted slightly later (Ve = 14-15 mL) than KC1-extracted 
G2000SW column
Bufferand symbolsas in Fig.5 nuclear receptors. Moreover, the nuclear receptor activity that remained in the Mg2-soluble chromatin fraction that was released by DNAase I had similar elution characteristics (Ve =15 niL). Although the extraction with NaSCN was less efficient, nuclear receptors that had been extracted with 500 mmol/L NaSCN were eluted similarly to KC1-extracted nuclear receptor (Figure 8 ). Thus, nuclear estrogen receptons released from chromatin by extraction with KC1 and NaSCN or treatment with DNAase I have rather similar elution properties on TSK-G2000SW columns. The slightly decreased elution of some receptor forms after exposure to DNAase I might be more related to minor proteolytic contaminants in the DNAase I than to authentic receptor properties.
Sensitivity of Steroid Receptor Analysis by SEHPLC
The lowest receptor activity that could be detected in fresh preparations of murine cytoplasmic estrogen receptors was approximately 5 fmol of receptor per irjection. Elution proffles were quite similar over a more than 30-fold concentration range (Figure 9 ): 6 to 824 fmol of receptor detected in injections of 24 to 800 tg of protein. We also evaluated the sensitivity of SEHPLC receptor analysis by using "Estrocept," a recently available commercial standard for estrogen receptor assays. With this standard we could compare our estimates of receptor activity from single-injection SEHPLC analysis with values obtained by an independent reference where, in contrast to rodent preparations (Figure 9) , nonspecific binding is higher and receptor activity per gram of soluble protein is lower. 26% ((6.7/25.8) x 1001. the range of expectation estimated from multi-point reference-laboratory data. Moreover, the average (± SD) SEHPLC estimate of receptor activity (26.02 ± 6.1 fmol of receptor per milligram of protein) was very similar to the estimate by the reference laboratory (25.8 ± 6.7 fmollmg).
Our final evaluation of the sensitivity of SEHPLC receptor analysis was based on human tumor material obtained by needle biopsy, detection of receptor activity in these very small biopsies being within the sensitivity of SEHPLC analysis. Figure  10 illustrates representative data from preparations containing abundant (E) and limited (F) nonspecific binding components. Nonspecific binding in these respective preparations (Ve = 11-15 and 21-29 mL) is adequately mirrored by Estrocept (Figure 10 ) and clearly discriminated in SEHPLC analyses so that equivalent specific binding could be estimated (Figure lOG, H) even though nonspecific binding was considerably different (Figure bE, F) . Although we in this laboratory have detected specific binding activity as low as 0.8 fmol/injection (Table  1) , a realistic operational limit is probably about 2 fmol of specific binding activity per injection.
Effects of Freezing and Lyophilization on SEHPLC Analysis of Receptor Activity
SEHPLC analyses of cytoplasmic estrogen receptor preparations that had been frozen at -70#{176}C for as long as eight weeks appeared qualitatively similar to the fresh preparation despite decreased quantitative activity after four weeks of frozen storage (note scale changes in Figure 11 ). This failure to resolve receptor breakdown into smaller receptor forms may be due to damaged receptors, which fail to reconstitute or which adhere to the column matrix. As suggested by Smith (33), frozen receptor preparations should be assayed within three to four weeks; moreover, SEHPLC analyses do not detect receptor breakdown or denaturation caused by freezing. Quantitative variability and decreased receptor activity were also observed in lyophilized preparations analyzed by SEHPLC (Figure 11) . Again, we did not observe smaller receptor forms, which might indicate receptor breakdown or denaturation, despite decreased binding activity after lyophilization.
Discussion
In these studies we have considered several factors relevant to the clinical analysis of steroid receptors by SEHPLC. We have identified the elution conditions that affect the performance and durability of TSK-SW columns for SEHPLC.
We have tried to define and present "reference" elution profiles of different receptor preparations that can be routinely obtained from murine uteri. Different cytoplasmic receptor forms generated in the presence of KC1, NaSCN, urea, and trypsin have been identified by SEHPLC. Moreover, cytoplasmic receptors activated in vitro were resolved separately from non-activated receptors on the TSK-G2000SW and eluted identically to extracted nuclear receptors. Because receptor activation is a prerequisite for receptor interaction with chromatin in the intact cell, the shift in receptor size that has been used as a marker for activation (1, 2, 31, 32) indicates that receptor activation can be documented on the TSK-G2000SW column. Finally, regardless of the method used to release nuclear estrogen receptors from chromatin (i.e., KC1, NaSCN, or DNAase I), these nuclear receptors have a remarkably similar elution behavior on the TSK-G2000SW column.
We explored the sensitivity of steroid receptor analysis by SEHPLC by using fresh murine preparations, a commercial- (34) (35) (36) (37) (38) (39) (40) (41) (42) . For the clinical analysis of steroid receptors the two most popular methods are sucrose-gradient sedimentation analysis and assay with use of dextran-coated charcoal (43). With sedimentation analysis a limited number of assay mixtures (as few as two) are centrifuged overnight to yield profiles of total binding activity and nonspecific binding activity. Thus, with this type of approach the demonstration of receptor activity appears to be assured by an appropriate sedimentation proffle and by the estimation of specific activity through the subtractive method. However, protracted sedimentation times (approximately 13 h) and the number of rotor tubes (six tubes) are obvious limitations of this method. When the assay with dextran-coated charcoal is used a rather large number of assay points (limited only by rotor capacity) are briefly exposed to the dextran-coated charcoal slurry (10 mm) and centrifuged (10 mm) so that specific activity can be more rapidly estimated after subtracting nonspecific binding from total binding activity. Ideally, a multi-point saturation analysis that is interpreted through use of a Scatchard plot is desirable. However, if the biopsied material is small, only a single saturation point determination can be used. It is difficult to be confident that random variation, variation in nonspecific binding components, and the cooperative ligand-binding properties of certain nonreceptor molecules do not influence the value obtained for a single estimate of saturation point specific binding. SEHPLC analysis provides a much more rapid alternative to sucrose gradient analysis, can accommodate more assay points per work day, and provides an elution proffle that confers a qualitative receptor characterization
(10-18).
Here, we have emphasized the utility of the TSK-G2000SW column. While the analytical performance of both the NK-G4000SW and TSK-G3000SW columns is sound, the TSK-G2000SW column has a longer useful life. Because the TSK-G2000SW column can discriminate large receptor forms (based on exclusion) from smaller receptor forms, which chrosnatograph differentially, the analyst in the clinical Analyseswere performedon a TSK-G3000SWcolumnwith P, buffercontainingdimethytformarnide(pH7.4) (75 mL/1)usedas the elutionbutter.Symbolsas In Fig. 2 laboratory has an opportunity to make a more informed choice as to whether or not to use SEHPLC for this analysis. Each of these compositionally homologous columns responds to the elution environment rather similarly, so the most important considerations are related to fractionation range and expectations as to useful column life. These considerations also must be made with the realization that those receptors associated with lack of response to hormonal therapy may be delineated through SEHPLC analysis.
